Acorda Therapeutics Hits Ch. 11, Plans $185M Drug Sale

By Yun Park · April 2, 2024, 11:29 AM EDT

Neurological disorders drugmaker Acorda Therapeutics Inc. filed for Chapter 11 protection in New York bankruptcy court, with plans to sell its assets to another pharmaceutical company for $185 million....

To view the full article, register now.